Chinese regulators focus on homegrown anti-COVID therapies: report

Seven homegrown drugs have been granted approval in the country.

Drug regulators in China have been focusing on approving homegrown antiviral therapies with the ability to tackle new COVID-19 variants, said a report from GlobalData.

The National Medical Products Administration (NMPA) of China has conditionally approved two homegrown oral drugs for the treatment of mild to moderate COVID-19.

According to GlobalData’s Pharma Intelligence Center, there are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the Phase III stage are targeting various subtypes of COVID-19 omicron variants.

Currently, seven homegrown Chinese drugs have been granted either official or conditional approval for treating COVID-19.

Anupama Mishra, pharma analyst at GlobalData, said there are very limited antiviral drugs currently marketed in China, raising a need to increase the number of approved therapies.

“It is important for Chinese pharmaceutical companies to increase market access by launching mass production and distribution of COVID-19 therapies at affordable consumer prices. Further approval of effective COVID-19 therapies will strengthen the healthcare infrastructure by increasing clinical recovery and thereby reducing hospitalizations,” said Mishra.

Follow the link for more news on

GlobalData

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit